Miller-Dieker syndrome synonyms

Miller-Dieker syndrome is primarily known by its eponym, but it is also clinically referred to as 17p13.3 deletion syndrome or lissencephaly-type 1. These synonyms reflect the condition's genetic origin, which involves a deletion of the short arm of chromosome 17, and its signature structural brain abnormality, lissencephaly (smooth brain).

What are the alternative names for Miller-Dieker syndrome?

In medical literature and clinical records, you may encounter several terms for Miller-Dieker syndrome. Because medical classification has evolved from purely descriptive terms to genetic definitions, the nomenclature can be confusing. The most common synonyms include:

• 17p13.3 deletion syndrome: This is the most accurate genetic descriptor, referring to the specific chromosomal region involved.


• Lissencephaly-type 1: This refers to the classic "smooth brain" appearance seen on imaging; however, this term is broader and can sometimes include other genetic conditions.


• Miller-Dieker lissencephaly syndrome: A slightly more descriptive version of the eponym.


• Chromosome 17p13.3 deletion syndrome: A technical variation of the primary genetic name.

Why does Miller-Dieker syndrome have multiple names?

The naming of Miller-Dieker syndrome is a result of the transition from historical, clinician-based naming to modern, molecular-based classification. Historically, the condition was named after the physicians (Miller and Dieker) who first described the clinical features in the 1960s. As medical technology advanced, researchers discovered that Miller-Dieker syndrome is caused by a contiguous gene deletion on chromosome 17. Consequently, the medical community began using "17p13.3 deletion syndrome" to provide a more precise, diagnostic, and actionable label for clinicians and geneticists.

What is the official classification of Miller-Dieker syndrome?

Major international databases standardize the name to ensure consistency in research and clinical care. In the Online Mendelian Inheritance in Man (OMIM) database, the condition is cataloged under the entry #247200. Orphanet, the reference portal for rare diseases, uses Miller-Dieker syndrome as the primary term while cross-referencing it with the chromosomal deletion. While these databases recognize the historical eponym, they emphasize the chromosomal location to aid in accurate diagnostic coding.

How do clinicians prefer to refer to the condition?

Most modern specialists, including clinical geneticists and neurologists, prefer the term Miller-Dieker syndrome for patient communication because it is the widely recognized name associated with established support networks. However, in laboratory reports and genetic counseling sessions, you will frequently see the term "17p13.3 deletion syndrome" used to highlight the specific genetic mechanism. Being aware of both terms is vital for patients and caregivers when searching for clinical trials or specialized care, as medical records may use these names interchangeably.

Next steps

• Consult with a clinical geneticist to review the specific chromosomal microarray results for your family member.


• Join the Miller-Dieker syndrome community on DiseaseMaps.org to connect with the 19 other members who have shared their experiences.


• Request that your neurologist or geneticist clarify which terminology is being used in your specific medical charts to ensure consistency across different specialists.


• Review updated clinical information on the NIH GARD website to stay informed about potential research opportunities.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding any medical condition.

References

• Orphanet: Miller-Dieker syndrome (ORPHA:2478)


• NIH GARD: Miller-Dieker syndrome (GARD ID: 7083)


• OMIM: Miller-Dieker Lissencephaly Syndrome (#247200)